Ryman Healthcare
RYM.NZ
#4295
Rank
S$2.68 B
Marketcap
$3.90
Share price
0.41%
Change (1 day)
-15.64%
Change (1 year)
Ryman Healthcare Limited is a company from New Zealand that operates retirement homes and clinics.

P/E ratio for Ryman Healthcare (RYM.NZ)

P/E ratio at the end of 2023: 10.4

According to Ryman Healthcare's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 9.40648. At the end of 2023 the company had a P/E ratio of 10.4.

P/E ratio history for Ryman Healthcare from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202310.481.75%
20225.74-62.4%
202115.3-20.78%
202019.319.31%
201916.243%
201811.311.72%
201710.1-15.73%
201612.0-6.39%
201512.8-16.35%
201415.316.08%
201313.242.49%
20129.27-0.03%
20119.27-16.5%
201011.1-2.77%
200911.427.73%
20088.94-57.92%
200721.215.77%
200618.338.78%
200513.227.11%
200410.46.42%
20039.77-37.61%
200215.713.72%
200113.8

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.